首页> 外文期刊>Clinical and applied thrombosis/hemostasis >Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation
【24h】

Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation

机译:血小板减少,血小板输注和肝移植后的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Thrombocytopenia affects patients undergoing liver transplantation. Intraoperative platelet transfusion has been shown to independently influence survival after liver transplantation at 1 and 5 years. We examined the impact of thrombocytopenia and intraoperative platelet transfusion on short-term graft and overall survival after orthotopic liver transplantation (OLT). A total of 399 patients undergoing first OLT were studied. Graft and overall survival in patients with different degrees of thrombocytopenia and with or without intraoperative platelet transfusion were described. The degree of thrombocytopenia prior to OLT did not affect graft or overall survival after transplant. However, graft survival in patients receiving platelets was significantly reduced at 1 year (P = .023) but not at 90 days (P = .093). Overall survival was significantly reduced at both 90 days (P = .040) and 1 year (P = .037) in patients receiving platelets. We conclude that a consistently lower graft and overall survival were observed in patients receiving intraoperative platelet transfusion.
机译:血小板减少症会影响接受肝移植的患者。术中血小板输注已显示独立影响肝移植后1年和5年的存活率。我们检查了血小板减少症和术中血小板输注对原位肝移植(OLT)后短期移植和总体存活的影响。共研究了399例首次接受OLT的患者。描述了不同程度的血小板减少和有或没有术中血小板输注的患者的移植物和总生存率。 OLT之前的血小板减少程度不影响移植物或移植后的整体存活率。但是,接受血小板治疗的患者的移植物存活率在1年时显着降低(P = .023),而在90天时则没有显着降低(P = .093)。接受血小板治疗的患者在90天(P = .040)和1年(P = .037)的总生存期均显着降低。我们得出的结论是,在接受术中血小板输注的患者中观察到移植物和总体生存率始终较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号